An approach quantifying both these mechanisms together, scaling and learning, is the experience curve concept, which estimates the investment costs at a certain cumulative installed capacity, without having detailed product specifications or cost indications.
However, as in the setting of acute trauma, significant issues of cost, indications, laboratory monitoring, safety, optimal dose, and use with blood products and other hemostatic agents remain to be established for rFVIIa use in patients without acute trauma who do not have hemophilia.
In this work, comments like calculation of total cost, indication of problem size are given for the published model of [Jo, J.B., Li, Y., & Gen, M. (2007). Nonlinear fixed charge transportation problem by spanning tree-based genetic algorithm. Computers & Industrial Engineering.
In 2008, comments like calculation of total cost, indication of problem size were given by Kannan et al. [Kannan, G., Kumar, P. S., Vinay V. P. (2008). Comments on ''Nonlinear fixed charge transportation problem by spanning tree-based genetic algorithm" by Jung-Bok Jo, Yinzhen Li, Mitsuo Gen, Computers & Industrial Engineering (2007). Computers & Industrial Engineering.
RAI is the proportion of cost-effective decisions, either reimbursement of cost-effective indications or non-reimbursement of cost-ineffective indications, out of total indications.
Based on the comparison between actual reimbursement decisions and the ICERs, we formulated a reimbursement adequacy index (RAI): calculating the proportion of cost-effective decisions, either reimbursement of cost-effective indications or non-reimbursement of cost-ineffective indications, out of the total number of indications for each country.
It is clear that this new technology opens the door for MRI to a growing number of patients; however, the widespread adoption of MRI-conditional devices will depend on real-life issues, such as cost, clinical indications for such a device and the permanent education of health care professionals.
Mr Papaconstantinou points to some encouraging signs: a rapid growth in goods exports in recent months, a significant fall in labour costs and indications that tourism will pick up later this year.But even if Greece is starting to become more competitive, it still has a long way to go.
Due to the need of manufacturers to recover development costs in indications with small patient numbers, orphan drugs tend to be more expensive than therapies in more prevalent disease areas.
The high costs, expanding indications, and rapidly increasing number of devices implanted will ultimately require important decisions to be made on the part of society, medical practitioners, and administrative agencies regarding how much we are willing to spend and for whom this expensive, yet effective, therapy should be provided.
On the other hand the high costs, expanding indications, and rapidly increasing number of devices implanted will ultimately require important decisions to be made on the part of society, clinicians, and administrative agencies in order to establish the potential amount of economic resources to spend on this expensive, yet effective, therapy.
